U.S. Implantable Medical Devices Market Analysis By Supply And Consumption Demand Analysis To 2021

U.S. Implantable Medical Devices Market: An in-depth analysis of statistics on current and emerging trends provides clarity regarding U.S. Implantable Medical Devices Market dynamics. The report includes Porter's five forces to analyze the importance of various characteristics such as understanding of suppliers and customers, risks posed by various agents, competitive strength, and promising emerging businessmen to understand a resource. Precious. Further, the report covers the research data of various companies, benefit, gross margin, global market strategic decisions, and more through tables, graphs, infographics, and figures.

The PDF for the study can be requested using the following link: https://www.coherentmarketinsights.com/insight/request-pdf/3853

Medical devices that are actively used make up a large part of the total implants market. Prosthetic devices, such as artificial organs, defibrillators, reconstructive joints, spinal implants, intraocular implants, breast implants, and others, are the most popular types of implantable medical devices. Implantable medical devices have two main functions: they apply therapy from the inside of an organ and they control the parameters and signals of the organ's functioning for treatment optimization.

Over the forecast period (2020-2027), the U.S. implantable medical devices market is expected to attain a valuation of US$ 150,299.3 million by 2027 and is approximated to reach a valuation of US$ 86,446.3 million in 2020.

Competitive Landscape

Key companies contributing in the U.S. implantable medical devices market are Medtronic Incorporated, Biomet Incorporated, Abbott Laboratories, Johnson and Johnson, Stryker Corporation, Zimmer Holdings Incorporated, Synthes Incorporated, Smith and Nephew PLC, Alcon Laboratories, Bausch and Lomb Incorporated, St. Jude Medical Incorporated, and Boston Scientific Corporation.

Drivers

Over the forecast period, the U.S. implantable medical devices market is expected to expand due to increased acceptance and launch of new products. Axonics Modulation Technologies, Inc. obtained premarket approval supplement approval from the US Food and Drug Administration in April 2020 for its next generation rechargeable implantable neurostimulator for its r-SNM System.

Opportunities

Medical implants made from additively produced and commercially pure biomaterials are expected to deliver lucrative growth opportunities for players operating in the U.S. implantable medical devices market. For instance, Researchers from the University Medical Centre Utrecht in the Netherlands published a study in April 2020 that found that bony defects treated with additively produced commercially pure titanium implants had higher volumes of regenerated bone than those treated with widely used titanium alloy.

Restraints

Rising product recalls are expected to hinder growth of the U.S. implantable medical devices market. Medtronic Plc, for example, received an FDA safety recall for implanted cardiac pacemakers in February 2019, affecting 13,440 products produced and distributed between March 2017 and January 2019.

Buy Now with Discount for Premium Report : (Flat USD 2000 Off) https://www.coherentmarketinsights.com/promo/buynow/3853

Key Takeaways:

Over the forecast period (2020-2027), the U.S. implantable medical devices market was valued at US$ 79,942.0 million in 2019 and is expected to reach US$ 150,299.3 million by 2027, with a CAGR of 8.2% between 2020 and 2027. Factors such as the rising prevalence of cardiovascular and orthopedic diseases, as well as advancements in implantable medical device technology, are all contributing to this trend.

Orthopedic implants dominated the implantable medical devices industry in the United States in 2019, accounting for 51.6 percent of market size, followed by cardiovascular implants and others. Over the forecast period, the segment is projected to expand due to an increase in the prevalence of orthopedic diseases. Product launches in the orthopedic implants market are also expected to boost the segment's development.

Market Trends

Medical implant R&D is expected to contribute to market expansion. Researchers from Tufts University in the United States, for example, published a novel thermal processing method for the direct solid-state molding of regenerated silk into bulk devices with tunable mechanical properties in December 2019.

Orthobiologics are substances that help to speed up the healing of bone injuries. These materials are extremely useful for repairing bone fractures as well as tendons, muscles, and ligament damage. Orthobiologic products are made up of substances that are naturally found in the human body. Due to growing geriatric population, the United States is considered the largest market for orthobiologics.

Key Developments

Exogenesis Corporation creates nanoMesh LLC, a new subsidiary charged with commercializing the Exogenesis Hernia Mesh, an advanced soft tissue repair implant, in April 2020.

Establishment Labs Holdings Inc. was awarded a patent in March 2020 to defend its patented breast implant surface technology.

Market Taxonomy

According to type of implant

Orthopedic Implants

Cardiovascular implants

Dental Implants

Intraocular Lens Implants

Breast Implants

Others

According to End User

Hospitals

Clinics

Others

Reasons to Purchase this Report

• Current and future of global U.S. Implantable Medical Devices Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3853

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.